The Official Journal of EuroPCR and the European Association of Percutaneous Coronary Interventions (EAPCI)

Editorial

To be better among the best: a difficult task

EuroIntervention 2021;16:1381-1383. DOI: 10.4244/EIJV16I17A251

1. Invasive Cardiology Unit, Humanitas Clinical and Research Center, IRCCS, Rozzano, Milan, Italy; 2. Department of Biomedical Sciences, Humanitas University, Pieve Emanuele, Milan, Italy


Drug-eluting stent (DES) implantation is the dominant revascularisation strategy for the treatment of ischaemic heart disease. Technological improvements led to a progressive reduction of the strut thickness, moving from 130 to 140 μm of the first-generation DES to the contemporary 50 and 60 μm of the latest generations1. The importance of strut thickness was first demonstrated in ISAR-STEREO 1 and 2 (Intracoronary Stenting and Angiographic Results Strut Thickness Effect on Restenosis Outcome), showing that the use of a thinner-strut bare metal stent (BMS) was associated with significant reduction of angiographic and clinical restenosis comparing stents with both the same or with a different ...

Sign in to read and download the full article

Forgot your password?
No account yet? Sign up for free!
Create my pcr account

Join us for free and access thousands of articles from EuroIntervention, as well as presentations, videos, cases from PCRonline.com

Read next article
How to eliminate mitral regurgitation definitively: the eternal dilemma?